A newly signed federal order aims to ease current restrictions on psychedelics, including ibogaine. The initiative calls on the government to expedite the review of these substances for potential therapeutic uses.

Order calls on federal government to relax restrictions on psychedelics, including ibogaine, for potential treatments.